Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals (NQ: RIGL )

3.540 USD UNCHANGED
Streaming Delayed Price Updated: 7:47 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Rigel Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Rigel Pharmaceuticals Provides Business Update
TAVALISSE® preliminary 2020 net product sales of approximately $61.7 million, a year-over-year increase of 41% 
From PR Newswire
XBI's Holdings Could Mean 41% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the 39th Annual J.P.... 
From PR Newswire
Good Things Can Come In Small Packages
There’s a misperception in the market that low-priced stocks can move faster than high-priced stocks. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
Financialnewsmedia.com News Commentary 
From PR Newswire
63 Biggest Movers From Yesterday
Gainers Upstart Holdings, Inc. (NASDAQ: UPST) shares surged 47.4% to close at $29.47 after the company priced its IPO at $20 per ... 
Tags RDUS CLLS Prescience Point
From Benzinga
Notable Wednesday Option Activity: RIGL, UNFI, ISEE
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rigel Pharmaceuticals Inc (RIGL), where a total of 51,763 contracts have traded so far,... 
Tags Stocks
From Market News Video
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers MIND Technology, Inc. (NASDAQ: MIND) climbed 52.5% to $2.70 after declining 28% on Tuesday. MIND Technology, earlier ... 
Tags Benzinga CDXC AOUT
From Benzinga
Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to TAVALISSE® (fostamatinib disodium hexahydrate) tablets will be presented in two poster presentations at the 62nd American... 
From PR Newswire
Analysts Forecast 23% Upside For The Holdings of IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
5 Penny Stocks On Robinhood To Buy Under $3; 1 With A 173% Target
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and Medison Pharma (Medison) today announced that Health Canada has approved the new drug submission (NDS) for TAVALISSE® (fostamatinib disodium hexahydrate)... 
From PR Newswire
Interesting RIGL Call Options For January 2021
Investors in Rigel Pharmaceuticals Inc (RIGL) saw new options begin trading this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RIGL... 
Tags Stocks
From Market News Video
Rigel Finalizes the Study Design of its Ongoing Phase 3 Clinical Trial of Fostamatinib in Warm Autoimmune Hemolytic Anemia
FDA agrees to the proposed primary efficacy endpoint and additional secondary endpoints 
From PR Newswire
Notable ETF Outflow Detected - LABU, RDUS, RGNX, RIGL
Symbols mentioned in this story: LABU, RDUS, RGNX, RIGL Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Rigel to Present at the Jefferies Virtual London Healthcare Conference
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual... 
From PR Newswire
Benzinga's Top Upgrades, Downgrades For November 9, 2020
Upgrades According to UBS, the prior rating for Yelp Inc (NYSE: YELP) was changed from Sell to Neutral. Yelp earned $0.01 in the ... 
Tags ALB TRUE FTI
From Benzinga
A Peek Into The Markets: US Stock Futures Jump Following Joe Biden's Victory
Pre-open movers U.S. stock futures traded higher in early pre-market trade following Joe Biden's victory in the Presidential ... 
Tags FFIV Markets OXY
From Benzinga
58 Stocks Moving In Friday's Mid-Day Session
Gainers Sundial Growers Inc. (NASDAQ: SNDL) climbed 64.5% to $0.3620 after gaining over 27% on Thursday. Sundial Growers is ... 
Tags Markets GLUU SNDL
From Benzinga
42 Stocks Moving in Friday's Pre-Market Session
Gainers FTS International, Inc. (NASDAQ: FTSI) rose 84.1% to $6.02 in pre-market trading after the company announced the ... 
Tags GBT ACTG INSG
From Benzinga
Rigel Reports Third Quarter 2020 Financial Results and Provides Business Update
Third quarter total revenues of $18.4 million 
From PR Newswire
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CTMX ARNA BIIB
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags YMAB HALO PACB
From Benzinga
Rigel Announces Conference Call and Webcast to Report Third Quarter 2020 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2020 financial results after market close on Thursday, November 5, 2020. Rigel senior management will... 
From PR Newswire
XBI's Underlying Holdings Could Mean 48% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of June 2021 Options Trading For Rigel Pharmaceuticals (RIGL)
Investors in Rigel Pharmaceuticals Inc (RIGL) saw new options become available this week, for the June 2021 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
Thinking about buying stock in Just Energy, Extreme Networks, Aurora Cannabis, AcelRx Pharmaceuticals, or Rigel Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for JE, EXTR, ACB, ACRX, and RIGL. 
From PR Newswire
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Trial being conducted at NIH Clinical Center in Bethesda, Maryland and Inova Fairfax Hospital in Virginia 
From PR Newswire
Either Analysts Got The Components Wrong or Russell 2000 Headed 22% Higher
The financial media loves to get predictions from experts about where they think a given stock market index is headed. Some experts look at technical analysis patterns, others look at valuation... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.